No worries @danishcookie
I welcome your half-glass empty to my half-glass full comments.
Patience will prevail.
Just BTW we will receive some more updates in between Sleep Apnoea and PSI-GAD,
PSI GAD is also split into circa 30 / 42 patients so I assume we will not have to wait for all 72 patients in the first instance?
I think the whole trial will take circa 12 months.
We can also expect
> results in vivo study on the protective effect of IHL-216A in traumatic brain injury and concussion (trial) nears conclusion
> US FDA pre-IND meeting for IHL-42X
> IHL-675 Phase 1, Clinical Trial Results
> New Psychedelic Trial anouncment
> New Left field Trial announcement
Also, these items give me a positive outlook ...
Good luck @danishcookie
- Forums
- ASX - By Stock
- IHL
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-19
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online